A controversial blood test aimed at detecting multiple cancers was backed by a U.S. Food and Drug Administration panel this week. On Wednesday, Sept. 23, the FDA's Molecular and Clinical Genetics ...
Only Abbott offers a complete screening solution combining end-to-end support with both stool- and blood-based colorectal cancer screening options, giving healthcare providers more ways to help ...
A screening test can determine if a person has an infection with hepatitis B. It involves a blood test that detects antigens and antibodies for hepatitis B virus (HBV). Hepatitis B, or hep B, is a ...
Freenome, Inc. (Nasdaq: FRNM), an early cancer detection company developing blood-based tests, today announced the company ...
Share on Pinterest A new screening test could help diagnose lung cancer earlier than traditional CT scans. Andriy Onufriyenko/Getty Images About 1.8 million deaths each year are attributable to lung ...
The US Food and Drug Administration has approved a blood test to be used for colorectal cancer screening among average-risk adults 45 and older. The maker of the test, Palo Alto, California-based ...
According to the former Fierce 15 winner, the test’s sensitivity was able to deliver a negative predictive value of 99.7%, or a 3-in-1,000 chance of lung cancer with a negative result. (Cecilia ...
LR+ = positive likelihood ratio; LR– = negative likelihood ratio; PSA = prostate-specific antigen; PSE = EpiSwitch prostate screening. *—Binary PSA is defined as a simple test using a fixed cutoff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results